Table of Contents 2
List of Tables 5
List of Figures 5
Cellceutix Corporation Spshot 6
Cellceutix Corporation Overview 6
Key Information 6
Key Facts 6
Cellceutix Corporation - Research and Development Overview 7
Key Therapeutic Areas 7
Cellceutix Corporation - Pipeline Review 14
Pipeline Products by Stage of Development 14
Pipeline Products - Monotherapy 15
Cellceutix Corporation - Pipeline Products Glance 16
Cellceutix Corporation - Clinical Stage Pipeline Products 16
Cellceutix Corporation - Early Stage Pipeline Products 18
Cellceutix Corporation - Drug Profiles 22
brilacidin tetrahydrochloride 22
KM-133 25
KM-3174 27
CC-1807 31
CTIX-1278 32
CTIX-1502 33
KM-277 34
KM-278 35
KM-362 36
KM-391 37
KM-732 39
PMX-0196 40
PMX-0243 41
PMX-10072 43
PMX-10098 44
PMX-1207 45
PMX-1241 46
PMX-1278 47
PMX-1405 48
PMX-1408 49
PMX-20005 51
PMX-207 52
PMX-225 53
PMX-231 55
PMX-255 57
PMX-30016 59
PMX-30024 60
PMX-496 61
PMX-504 62
PMX-519 63
PMX-611 65
PMX-647 66
PMX-835 67
Small Molecule to Disrupt Cell Membrane for Hidradenitis Suppurativa 68
PMX-100 69
PMX-1014 71
PMX-1045 72
PMX-1056 73
PMX-1057 74
PMX-1090 75
PMX-1091 76
PMX-1094 77
PMX-1099 78
PMX-1102 79
PMX-1142 80
PMX-1363 81
PMX-1424 82
PMX-1442 83
PMX-1445 84
PMX-1467 85
PMX-1488 86
PMX-1533 87
PMX-1547 88
PMX-1555 89
PMX-1560 90
PMX-1570 91
PMX-1572 92
PMX-1573 93
PMX-1576 94
PMX-1591 95
PMX-1625 96
PMX-183 97
PMX-223 98
PMX-229 99
PMX-247 100
PMX-520 101
PMX-633 102
PMX-668 103
PMX-693 104
PMX-70004 105
PMX-728 107
PMX-741 108
PMX-843 109
PMX-868 110
Cellceutix Corporation - Pipeline Alysis 111
Cellceutix Corporation - Pipeline Products by Target 111
Cellceutix Corporation - Pipeline Products by Route of Administration 112
Cellceutix Corporation - Pipeline Products by Molecule Type 113
Cellceutix Corporation - Pipeline Products by Mechanism of Action 114
Cellceutix Corporation - Recent Pipeline Updates 115
Cellceutix Corporation - Dormant Projects 149
Cellceutix Corporation - Locations And Subsidiaries 150
Head Office 150
Appendix 151
Methodology 151
Coverage 151
Secondary Research 151
Primary Research 151
Expert Panel Validation 151
Contact Us 151
Disclaimer 152